Immuneering Corporation Class A Common Stock
Symbol: IMRX (NASDAQ)
8.62
▲ (22.27%) 1.570
Company Description:
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
Key Stats
- Today's Open: $7.99
- Today's High: $9.33
- Today's Low: $7.025
- Today's Volume: 3.32M
- Yesterday Close: $7.05
- Yesterday High: $7.16
- Yesterday Low: $5.97
- Yesterday Volume: 1.67M
- Last Min Volume: 1
- Last Min High: $8.62
- Last Min Low: $8.62
- Last Min VWAP: $8.62
Company Profile
- Name: Immuneering Corporation Class A Common Stock
- Website: https://www.immuneering.com
- Listed Date: 2021-07-30
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001790340
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $247.34M
- Round Lot: 100
- Outstanding Shares: 41.57M
- Asset Type: CS
RECENT FILINGS FOR IMRX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | D | View |
| 2025-09-08 | EFFECT | View |
| 2025-09-08 | 424B3 | View |
| 2025-09-03 | S-3 | View |
| 2025-08-25 | 8-K | View |
| 2025-08-20 | EFFECT | View |
| 2025-08-13 | S-3 | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-07-07 | 4 | View |
| 2025-07-07 | 4 | View |
| 2025-07-03 | 4 | View |
| 2025-06-30 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-24 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 424B5 | View |
| 2025-06-20 | 4 | View |
| 2025-06-18 | 4 | View |
| 2025-06-17 | 8-K | View |
Latest News on IMRX